ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 160 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,556,000 | +100.0% | 119,925 | +5.2% | 0.00% | +50.0% |
Q1 2019 | $2,778,000 | +116.7% | 113,943 | +26.6% | 0.00% | +100.0% |
Q4 2018 | $1,282,000 | +11.6% | 89,972 | +19.0% | 0.00% | 0.0% |
Q3 2018 | $1,149,000 | -10.4% | 75,632 | -1.0% | 0.00% | 0.0% |
Q2 2018 | $1,282,000 | -2.7% | 76,399 | -5.3% | 0.00% | 0.0% |
Q1 2018 | $1,317,000 | -1.1% | 80,685 | -22.3% | 0.00% | 0.0% |
Q4 2017 | $1,331,000 | +32.8% | 103,783 | +27.2% | 0.00% | 0.0% |
Q3 2017 | $1,002,000 | +77.0% | 81,578 | +20.6% | 0.00% | – |
Q2 2017 | $566,000 | +13.2% | 67,656 | +20.6% | 0.00% | – |
Q1 2017 | $500,000 | +39.7% | 56,110 | +37.3% | 0.00% | – |
Q4 2016 | $358,000 | +145.2% | 40,854 | +76.0% | 0.00% | – |
Q3 2016 | $146,000 | +78.0% | 23,211 | 0.0% | 0.00% | – |
Q2 2016 | $82,000 | +17.1% | 23,211 | 0.0% | 0.00% | – |
Q1 2016 | $70,000 | -34.0% | 23,211 | -9.5% | 0.00% | – |
Q4 2015 | $106,000 | -11.7% | 25,657 | 0.0% | 0.00% | – |
Q3 2015 | $120,000 | -35.1% | 25,657 | 0.0% | 0.00% | – |
Q2 2015 | $185,000 | -3.6% | 25,657 | 0.0% | 0.00% | – |
Q1 2015 | $192,000 | +56.1% | 25,657 | 0.0% | 0.00% | – |
Q4 2014 | $123,000 | +28.1% | 25,657 | 0.0% | 0.00% | – |
Q3 2014 | $96,000 | – | 25,657 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |